<SEC-DOCUMENT>0001062993-23-015048.txt : 20230718
<SEC-HEADER>0001062993-23-015048.hdr.sgml : 20230718
<ACCEPTANCE-DATETIME>20230718203124
ACCESSION NUMBER:		0001062993-23-015048
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230714
FILED AS OF DATE:		20230718
DATE AS OF CHANGE:		20230718

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bariahtaris Steven
		CENTRAL INDEX KEY:			0001822217

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40228
		FILM NUMBER:		231095402

	MAIL ADDRESS:	
		STREET 1:		C/O CARMELL THERAPEUTICS CORPORATION
		STREET 2:		2403 SIDNEY STREET, SUITE 300
		CITY:			PITTSBURGH
		STATE:			PA
		ZIP:			15203

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALPHA HEALTHCARE ACQUISITION CORP III
		CENTRAL INDEX KEY:			0001842939
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1177 AVENUE OF THE AMERICAS
		STREET 2:		5TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		646-494-3296

	MAIL ADDRESS:	
		STREET 1:		1177 AVENUE OF THE AMERICAS
		STREET 2:		5TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2023-07-14</periodOfReport>

    <issuer>
        <issuerCik>0001842939</issuerCik>
        <issuerName>ALPHA HEALTHCARE ACQUISITION CORP III</issuerName>
        <issuerTradingSymbol>CTCX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001822217</rptOwnerCik>
            <rptOwnerName>Bariahtaris Steven</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CARMELL THERAPEUTICS CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>2403 SIDNEY STREET, SUITE 300</rptOwnerStreet2>
            <rptOwnerCity>PITTSBURGH</rptOwnerCity>
            <rptOwnerState>PA</rptOwnerState>
            <rptOwnerZipCode>15203</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.11</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2023-07-14</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>76878</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2031-09-23</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>76878</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>76878</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Options to purchase 76878 shares of common stock of Legacy Carmell (as defined below) granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date.</footnote>
        <footnote id="F2">On July 14, 2023, Alpha Healthcare Acquisition Corp. III (&quot;ALPA&quot;) consummated a business combination (the &quot;Business Combination&quot;) by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (&quot;Merger Sub&quot;) and Carmell Regen Med Corporation, a Delaware corporation (&quot;Legacy Carmell&quot;), ALPA changed its name to &quot;Carmell Therapeutics Corporation&quot; and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Randolph W. Hubbell, Attorney-in-Fact</signatureName>
        <signatureDate>2023-07-18</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
